ASPX

AUSPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers

moreView todays social media effects on ASPXView the latest stocks trending across Twitter. Click to view dashboardSee who Auspex is hiring next, click here to view […]

May 7, 2014 Bystocknews ASPX, stock Comments Off read more

Auspex Pharmaceuticals Appoints Industry Veterans Lynn Bleil And Scott Greer To Its Board Of Directors

[PR Newswire] – LA JOLLA, Calif., May 7, 2014 /PRNewswire/ — Auspex Pharmaceuticals, Inc. (ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today annou moreView todays social media effects on ASPXView the latest stocks trending across Twitter. Click to view dashboardSee who Auspex is hiring next, click here […]

May 7, 2014 Bystocknews ASPX, stock Comments Off read more

AUSPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers

Auspex Pharmaceuticals Appoints Industry Veterans Lynn Bleil And Scott Greer To Its Board Of Directors

4:01 pm Auspex Systems announces the issuance of patents on deuterium-containing form of Pirfenidone (SD-560)

Cramer: Could this stock surge on the IPO?

Coverage initiated on Auspex Systems by Robert W. Baird, Stifel and William Blair

Coverage initiated on Auspex Systems by Robert W. Baird and Stifel

Innovation In Huntington’s Disease: Auspex Vs. Rivals

AUSPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin

U.S. IPO Recap: Revance Jumps 68% In 10 IPO Week